Sernova

London, Canada Founded: 1998 • Age: 28 yrs
Regenerative medicine to deliver proteins and hormones for disease treatment
Request Access

About Sernova

Sernova is a company based in London (Canada) founded in 1998.. The company has 17 employees as of October 31, 2024. Sernova offers products and services including Cell Pouch™. Sernova operates in a competitive market with competitors including NGM Biopharmaceuticals, MannKind Corp, Rhythm Pharmaceuticals, Corcept and ViaCyte, among others.

  • Headquarter London, Canada
  • Employees 17 as on 31 Oct, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sernova Biotherapeutics Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $0 (USD)
    0
    as on Oct 31, 2024
  • Net Profit
    $-22.37 M (USD)
    17.45
    as on Oct 31, 2024
  • EBITDA
    $-21.75 M (USD)
    23.07
    as on Oct 31, 2024
  • Latest Funding Round
    $694.48 K (USD), Post-IPO

    Mar 04, 2025

  • Investors
  • Employee Count
    17

    as on Oct 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Sernova

Sernova is a publicly listed company on the TSX with ticker symbol SVA in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: TSX · Ticker: SVA . Sector: Health technology · Canada

Products & Services of Sernova

Sernova offers a comprehensive portfolio of products and services, including Cell Pouch™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device that restores bodily functions for chronic disease patients.

People of Sernova
Headcount 10-50
Employee Profiles 3
Employee Profiles
People
Dan Mahony
Non Executive Director
People
Robert Gabbay M.D.
Clinical Advisor

Unlock access to complete

Funding Insights of Sernova

  • Total Funding
  • Total Rounds 27
  • Last Round Post-IPO — $694,480
  • First Round

    (26 Feb 2001)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2025 Amount Post-IPO - Sernova Valuation

investors

Sep, 2024 Amount Post-IPO - Sernova Valuation

investors

Sep, 2022 Amount Post-IPO - Sernova Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sernova

Sernova has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include National Research Council Canada and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Scientific and technological research is conducted for Canada's benefit.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sernova

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Sernova

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sernova Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sernova

Sernova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NGM Biopharmaceuticals, MannKind Corp, Rhythm Pharmaceuticals, Corcept and ViaCyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biologics are developed for cardio-metabolic and liver diseases.
domain founded_year HQ Location
Developer of small-molecule drugs
domain founded_year HQ Location
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
domain founded_year HQ Location
Developer of cortisol modulators for the treatment of various diseases
domain founded_year HQ Location
Cell therapy for diabetes is developed from stem cells.
domain founded_year HQ Location
Developer of therapies for treating nonalcoholic steatohepatitis and other liver and metabolic disorders
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Sernova

When was Sernova founded?

Sernova was founded in 1998 and raised its 1st funding round 3 years after it was founded.

Where is Sernova located?

Sernova is headquartered in London, Canada. It is registered at London, Ontario, Canada.

How many employees does Sernova have?

As of Oct 31, 2024, the latest employee count at Sernova is 17.

What does Sernova do?

Sernova Corp. was founded in 1998 in London, Canada, as a regenerative medicine company. Therapeutic cells are transplanted using the Cell Pouch, an implantable device designed for long-term release of proteins and hormones to address conditions like diabetes, hemophilia, and thyroid disease. Sertolin, a cell-based immune protection technology, is being developed to minimize anti-rejection drug needs. Clinical efforts are primarily directed toward insulin-dependent diabetes treatment.

Who are the top competitors of Sernova?

Sernova's top competitors include Rhythm Pharmaceuticals, MannKind Corp and Corcept.

What products or services does Sernova offer?

Sernova offers Cell Pouch™.

Is Sernova publicly traded?

Yes, Sernova is publicly traded on TSX under the ticker symbol SVA.

Who are Sernova's investors?

Sernova has 2 investors. Key investors include National Research Council Canada, and European Union.

What is Sernova's ticker symbol?

The ticker symbol of Sernova is SVA on TSX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available